Myelosuppression, or bone marrow suppression, is defined as a decrease in the ability of the bone marrow to produce blood cells. This may result in a lack of red blood cells (anemia), white blood ...

Vaccine effectiveness relies on creating a strong antibody response that can be reactivated to fight future infections. Now, ...

Zydus Lifesciences on Wednesday said it has launched ANVIMO, a breakthrough medication for the prevention of Cytomegalovirus ...

Red blood cells carry oxygen from the lungs to every other organ, and blood-forming stem cells must make about 200 billion new red blood cells each day to keep the oxygen flowing. For many years, ...

Pharma major, Zydus Lifesciences on Wednesday said that it has launched ANVIMO (Letermovir), a new and innovative treatment ...

A bone marrow transplant process is safe and curative for adults with sickle cell disease, according to results of a trial completed at about 20 cancer centers. A bone marrow transplant process co ...

Zydus Lifesciences introduces ANVIMO, a cost-effective medication for preventing CMV infection in transplant patients, ...

Dr. King discusses the impact of receiving an AAMDSIF research grant on her career and her study of bone marrow failure. Her research on the effects of inflammatory signaling on bone marrow stem cells ...

Traditional CMV treatments, such as ganciclovir and valganciclovir, have notable limitations, including toxicity and bone ...

Zydus Lifesciences launches ANVIMO, a breakthrough drug for preventing Cytomegalovirus infection in transplant patients, ...